Skip to main content
. 2019 Nov 1;43(1):3–15. doi: 10.3892/or.2019.7397

Figure 3.

Figure 3.

Relationship between HIF and HCC. The complex relationship between HIF and HCC includes metabolism, immune escape, angiogenesis, metastasis, extracellular matrix remodeling, and cancer stem cells. ALD, aldolase; AK3, adenylate kinase 3; CA9, carbonic anhydrase 9; CCL20, CAFs, cancer-related fibroblasts; C-C motif chemokine ligand 20; ECM, extracellular matrix; EMT, epithelial-mesenchymal transition; ENO1, enolase 1; EPO, erythropoietin; GLUT, glucose transporter; HK, hexokinase; LOX, lysyl oxidase; MMPs, matrix metalloproteinases; NOX4, NADPH oxidase 4; P4Hs, prolyl-4-hydroxylases; PDGF, platelet-derived growth factor; PFKFB, 3,6-phosphofructo-2-kinase/fructose-2,6-bisphosphate 3; PFKL, liver-type phosphofructokinase; PGF, placental growth factor; PGK1, phosphoglycerate kinase 1; PLODs, procollagen lysyl hydroxylases; TAM, tumor-associated macrophage; TGF-β, transforming growth factor β; TIE-2, tyrosine-protein kinase receptor TIE-2; TIMP2, tissue inhibitor of metalloproteinase 2; TUFT1, tuftelin1; VEGF, vascular endothelial growth factor.